IV. 8. Life Stages of the Microbiota

Your microbiome builds in infancy, matures through childhood, stabilizes in adulthood, transforms during pregnancy and lactation, and declines with age — though far less inevitably than once thought — and this chapter gives the typical pattern and maintenance levers for each stage.

Your microbiome isn't the same at every stage of your life. In infancy it develops; in childhood it matures toward its adult form; in adulthood it's relatively stable; in pregnancy and lactation it shifts substantially; in old age its diversity declines — especially when not accompanied by a microbiome-aware lifestyle.

This chapter walks through the stages: infancy → childhood → adulthood → pregnancy and lactation → old age. Each stage gets age-specific patterns, typical clinical issues, and maintenance levers.

Fetal life and birth

For decades the microbiome was assumed to start at birth, but the last 10 years of research have rewritten that picture from the ground up. The final weeks of fetal life and the mode of delivery together establish the initial microbial fingerprint that shapes the next 2–3 years of colonization. The stakes here are high: the microbiome forming in the 0–3 window has lasting effects on immune maturation, allergy/atopy risk, and metabolic programming. Damage occurring during or right after birth can be corrected most effectively during this period. The subsections below cover fetal transfer, vaginal versus cesarean delivery differences, and the impact of peripartum antibiotics.

End of the "sterile fetus" dogma

For 20–30 years clinical texts asserted the fetus was sterile in the womb; microbiome development began only at birth. Recent years have refined this: trace bacterial DNA and metabolites are detectable in the placenta, amniotic fluid, and fetal gut — but quantities are so small that the functional microbiome truly begins with birth. [619]

Vaginal vs. C-section delivery

A vaginally born infant's first microbiota reflects the mother's vaginal and perineal flora (Lactobacillus, Prevotella). A C-section infant, by contrast, receives the mother's and environmental skin microbiota (Staphylococcus, Streptococcus, hospital environmental bacteria). [238]

This doesn't mean C-section is "bad" — when medically indicated it saves lives. But the microbiome-level difference is real and significantly associated with outcomes: higher infant antibiotic need, slight increase in associated allergy/asthma/atopic dermatitis risk (see chapter 3's zone), and slight childhood obesity risk increase (still debated).

Vaginal seeding — evidence and risk

Vaginal seeding (swabbing a C-section-born newborn's mouth and skin with maternal vaginal secretion) has been a contested intervention in the past 10 years. Evidence is limited: small studies showed microbiome convergence, but long-term health benefit isn't proven. The risk, however, is real: maternal Streptococcus agalactiae (group B), H. simplex, gonorrhea, and chlamydia must be screened beforehand. Modern protocol suggests B. infantis restoration (see below) as a more scientifically grounded alternative.

Infancy (0–24 months)

The infant microbiome changes more dramatically in the first two years of life than in any other stage: from a Bifidobacterium-dominant starter community of a few species, a near-adult ecosystem with hundreds of species assembles in 24 months. This window is more than microbial development — immune system maturation, gut barrier construction, and metabolic tolerance calibration all happen in parallel. The subsections below cover the role of breast milk, the timing of solid food introduction, and the most common disruptors (antibiotics, early formula introduction, excessive hygiene).

Breast milk, HMOs, and Bifidobacterium infantis

Breast milk is nature's most refined prebiotic. It contains human milk oligosaccharides (HMOs) — over 200 distinct oligosaccharides that the infant can't digest, but Bifidobacterium infantis (and a few of its close relatives) can. The HMO-consuming B. infantis is a key player in a healthy infant gut microbiome: it lowers pH, outcompetes pathogens, and delivers immune-maturation signals.

The modern problem is that ~70% of Western infants are missing it, or have very little B. infantis. The causes accumulate: formula use (HMO content was limited or absent for a long time — many newer formulas now include HMOs), C-section delivery, infant antibiotic courses, and excessive household sterilization all contribute.

Infant antibiotics

The 0–24 month window is the most critical microbiota period. Bokulich et al. 2016 Sci Transl Med tracked longer-term consequences of infant antibiotic exposure: reduced diversity, slower maturation, and association with later atopy and obesity risk. [599] Some hypotheses suggest that complex antibiotic therapy given in infancy may also contribute to the development of certain types of ASD.

The clinical message is twofold. When indicated (bacterial infection), AB is necessary and life-saving — no reason to withhold it. When unindicated (viral upper respiratory infection, "just in case"), avoid it. Pediatric guidelines are tightening on this front, and as a parent it's worth asking the pediatrician whether a bacterial infection actually justifies the AB.

Solid food introduction

Solid food introduced from 4–6 months is a new step in microbiome maturation. More diverse solids — more vegetables, legumes, whole grains — lead to a richer microbiome by age 2. [623] Modern allergy guidelines (EAACI 2014) recommend early introduction of allergenic foods (peanut, egg) from 4 months, because delay increases allergy risk.

Childhood and adolescence

By age 3, the child's microbiome has reached its adult-like base structure, but fine-tuning continues until age 12–14. Two main themes deserve attention.

The hygiene vs. biodiversity hypothesis is one. The classic hygiene hypothesis (Strachan 1989) holds that overly sterilized environments increase atopy risk. The modern biodiversity hypothesis is more nuanced: the benefit isn't dirt per se but environmental microbial diversity — contact with nature, soil, animals, and agricultural environments. [624] Practical implications: prioritize time in nature, consider pets (dog, cat — meaningful microbiome benefit from infancy), and minimize too-frequent, too-aggressive cleaning products (chapter 6's EDC section).

Adolescence is another microbiome transition period: hormonal changes (especially estrogen mediation) affect the microbiome in both sexes.

Adulthood — stability and resilience

The adult microbiome is relatively stable but not fixed. The chapter 4–7 lifestyle levers act here most directly and measurably. A lifestyle-consistent adult shows a similar baseline microbiome years on — a lifestyle-changing adult shows measurable shift within 4–8 weeks.

Some adult-specific themes deserve attention. Work stress (chapter 5) and travel (traveler's diarrhea, jet lag) are common microbiome stressors. Starting chronic medication (PPIs, NSAIDs, antihypertensives — chapter 7) gradually but meaningfully reshapes the microbiome. Life transitions (childbearing, divorce, grief) all carry meaningful microbiome stress, and this is worth addressing intentionally — even with chapter 5's stress-management levers.

Pregnancy and lactation

The microbiome shift associated with pregnancy is physiological — its purpose is preparing the mother energetically for fetal growth. In the third trimester, the microbiome shifts substantially toward Firmicutes, which would look like a metabolic syndrome sign in a healthy non-pregnant woman, but in pregnancy is adaptive.

Two clinical questions in pregnancy deserve particular attention.

• Probiotic safety: selected strains (LGG, S. boulardii) are considered safe in pregnancy, but general probiotic use is worth discussing with a specialist — especially in the first trimester, because non-targeted probiotic treatment can itself lead to dysbiosis.
• AB avoidance, where clinically possible, is valuable for allergy prevention (see chapter 3 ). GBS (group B strep) screening at 35–37 weeks is standard, and positive cases require intrapartum AB prophylaxis (this also affects the infant microbiome, short term — but GBS infection prevention is by far the priority).
• Gestational diabetes and its microbiome link belong to chapter 3's orange zone.

The direct microbiome effect of breastfeeding is also significant. Breast milk contains not only HMOs but also live bacteria (~10⁴–10⁶ CFU/ml) — Lactobacillus, Streptococcus, Bifidobacterium, Staphylococcus — which actively transfer to the infant's microbiome. [625] This is one of the main mechanisms of passive immunity transfer and microbiota seeding.

Old age and inflammaging

The "normal" age-related change has four main features: reduced microbial diversity, decreased Bifidobacterium abundance, increased Proteobacteria frequency, and the emergence of chronic low-grade inflammation (the so-called inflammaging).

But — and this is one of the chapter's most important messages — age-related change isn't necessarily pathological. The microbiome profiles of centenarians and supercentenarians (110+) resemble active adults more than typical 70–80 year-olds. Meaning age-related diversity loss derives at least partly from lifestyle factors (reduced dietary variety, sedentary life, social isolation, polypharmacy), not just from age. [626]

Five clinical foci matter in old age.

• Dietary diversity maintenance — fiber intake typically declines in old age, and this needs to be actively counteracted.
• Movement — even 2 short walks per week make a meaningful difference, no marathon needed.
• Social connection — isolation is an independent microbiome risk factor, with a stronger effect than many recognize.
• Polypharmacy review — 5+ medications accumulated by old age (PPI, NSAID, statin, antihypertensive) cause meaningful microbiome burden; an annual pharmacist deprescribing review may be needed.
• Finally, frailty prevention: protein intake + movement + social activity combined.

Life-stage decision table

What you can do tomorrow

Your profile determines which life stage is active for you.

• As parents of infants: breastfeed as long as feasible; if formula is needed, choose HMO-containing; AB only when indicated.
• As parents of children: at least one weekly outdoor session, multiple vegetables in the weekly diet, a pet at home if possible.
• As an adult: chapters 4–7 per your profile.
• For an elderly parent or family member: review their polypharmacy list (request a pharmacist review), build dietary diversity (small portions, many varieties), and actively support social connections — this isn't "being nice," it's a measurable health benefit.

What's next

Chapter 9 takes genetics and personalization: how much your microbiome is shaped by your genes, and when microbiome testing is worth doing (or not) — the latter leads to chapter 10.

References

[238] Dominguez-Bello MG, Costello EK, Contreras M et al. Delivery mode shapes the acquisition and structure of the initial microbiota across multiple body habitats in newborns. Proc Natl Acad Sci USA. 2010. Link

This study used multiplexed 16S rRNA pyrosequencing to characterize bacterial communities from 10 mother-newborn dyads (4 vaginal, 6 cesarean deliveries), sampling mothers' skin, oral and vaginal sites pre-delivery and neonatal skin, oral, nasopharyngeal aspirate and meconium within 24 hours. Delivery mode strongly shaped neonatal microbiota establishment across all body habitats: vaginally born infants harboured communities resembling maternal vaginal microbiota, while C-section infants resembled maternal skin. The findings document the foundational influence of delivery mode on the initial human microbiome.

[599] Bokulich NA, Chung J, Battaglia T et al. Antibiotics, birth mode, and diet shape microbiome maturation during early life. Sci Transl Med. 2016. Link

Microbial development was profiled in 43 US infants over the first two years of life. Early-life exposures — antibiotic use, cesarean section and formula feeding — were associated with disrupted establishment of maternal bacteria, delayed microbiome development and altered α-diversity. These findings illustrate the complexity of early-life microbiome maturation and its sensitivity to common perturbations during the critical neonatal window — relevant to long-term immune and metabolic risk.

[619] Mishra A, Lai GC, Yao LJ et al. Microbial exposure during early human development primes fetal immune cells. Cell. 2021. Link

Fetal immune-priming was explored by profiling microbial signals across fetal organs using 16S rRNA sequencing. Low but consistent microbial signals were detected in fetal gut, skin, placenta and lungs during the 2nd trimester. Several live bacteria — including Staphylococcus and Lactobacillus — were isolated and induced in vitro activation of memory T cells in fetal mesenteric lymph node. SEM and RNA-ISH visualized bacteria-like structures and eubacterial RNA within the 14-week fetal gut lumen, supporting selective live-microbe presence and a role in pre-birth immune priming. (Interpretation is contested — see ref-558 and ref-479.)

[623] Stewart CJ, Ajami NJ, O'Brien JL et al. Temporal development of the gut microbiome in early childhood from the TEDDY study. Nature. 2018. Link

TEDDY-study longitudinal stool samples (3–46 months of age) from 903 children — 12 005 16S rRNA and 10 867 metagenomic samples — defined three developmental phases of the gut microbiome: developmental (months 3–14), transitional (months 15–30) and stable (months 31–46). Receipt of breast milk (exclusive or partial) was the most significant factor influencing microbiome structure; breastfeeding was associated with higher Bifidobacterium species (B. breve, B. bifidum), and cessation of breastfeeding accelerated Firmicutes-marked maturation. The findings characterize microbial-immune cross-talk relevant to islet autoimmunity and type 1 diabetes development.

[624] von Hertzen L, Hanski I, Haahtela T. Natural immunity. Biodiversity loss and inflammatory diseases are two global megatrends that might be related. EMBO Rep. 2011. Link

Von Hertzen, Hanski and Haahtela's 2011 EMBO Reports commentary 'Natural immunity. Biodiversity loss and inflammatory diseases are two global megatrends that might be related' synthesises an ecological-immunological perspective linking declining environmental biodiversity to the rising burden of inflammatory and allergic disease. The authors propose that reduced contact with diverse environmental microbes — driven by urbanisation, antiseptic environments, processed food and loss of biodiverse landscapes — impairs immune tolerance training in early life, contributing to allergy, asthma, IBD and autoimmune disease. They link the hygiene/'old friends' hypothesis to global biodiversity-loss data and call for environmental health policy integrating microbiome exposure as a public-health intervention. The article is a foundational reference for the biodiversity-microbiome-health framework.

[625] Fitzstevens JL, Smith KC, Hagadorn JI et al. Systematic review of the human milk microbiota. Nutr Clin Pract. 2017. Link

A systematic review of PubMed (Jan 1964 – June 2015) characterized the microbiota of human milk. Twelve studies met the inclusion criteria (healthy mothers, English-language, identifying bacteria in human milk by culture-independent methods, reporting results at genus level). Studies varied in geography and in milk collection, storage and analytic methods. Human-milk microbes appear to colonize the infant gut early and may influence short- and long-term infant health outcomes; methodological heterogeneity limits cross-study comparison and underscores the need for standardized protocols.

[626] Biagi E, Nylund L, Candela M et al. Through ageing, and beyond: gut microbiota and inflammatory status in seniors and centenarians. PLoS One. 2010. Link

Gut microbiota of young adults, elderly and centenarians (>100 years) were profiled by HITChip and qPCR of 16S rRNA. Young adults and 70-year-olds had highly similar microbiota; centenarians differed significantly. After 100 years of symbiosis, the microbiota showed Firmicutes rearrangement and enrichment of facultative anaerobes including pathobionts. The compromised microbiota was associated with 'inflammageing' — elevated inflammatory markers in peripheral blood — partly explained by marked decrease of anti-inflammatory Faecalibacterium prausnitzii and relatives in centenarians.